These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 29498118

  • 1. Inhibition of amyloid beta fibril formation by monomeric human transthyretin.
    Garai K, Posey AE, Li X, Buxbaum JN, Pappu RV.
    Protein Sci; 2018 Jul; 27(7):1252-1261. PubMed ID: 29498118
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Transthyretin variants with improved inhibition of β-amyloid aggregation.
    Mangrolia P, Yang DT, Murphy RM.
    Protein Eng Des Sel; 2016 Jun; 29(6):209-218. PubMed ID: 27099354
    [Abstract] [Full Text] [Related]

  • 7. Transthyretin as both a sensor and a scavenger of β-amyloid oligomers.
    Yang DT, Joshi G, Cho PY, Johnson JA, Murphy RM.
    Biochemistry; 2013 Apr 30; 52(17):2849-61. PubMed ID: 23570378
    [Abstract] [Full Text] [Related]

  • 8. S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro.
    Zhang W, Du Y, Bai M, Xi Y, Li Z, Miao J.
    J Pept Sci; 2013 Mar 30; 19(3):159-65. PubMed ID: 23349038
    [Abstract] [Full Text] [Related]

  • 9. Transthyretin suppresses the toxicity of oligomers formed by misfolded proteins in vitro.
    Cascella R, Conti S, Mannini B, Li X, Buxbaum JN, Tiribilli B, Chiti F, Cecchi C.
    Biochim Biophys Acta; 2013 Dec 30; 1832(12):2302-14. PubMed ID: 24075940
    [Abstract] [Full Text] [Related]

  • 10. Transthyretin aggregation under partially denaturing conditions is a downhill polymerization.
    Hurshman AR, White JT, Powers ET, Kelly JW.
    Biochemistry; 2004 Jun 15; 43(23):7365-81. PubMed ID: 15182180
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mechanisms of transthyretin inhibition of β-amyloid aggregation in vitro.
    Li X, Zhang X, Ladiwala AR, Du D, Yadav JK, Tessier PM, Wright PE, Kelly JW, Buxbaum JN.
    J Neurosci; 2013 Dec 11; 33(50):19423-33. PubMed ID: 24336709
    [Abstract] [Full Text] [Related]

  • 13. Transthyretin Mimetics as Anti-β-Amyloid Agents: A Comparison of Peptide and Protein Approaches.
    Pate KM, Kim BJ, Shusta EV, Murphy RM.
    ChemMedChem; 2018 May 08; 13(9):968-979. PubMed ID: 29512286
    [Abstract] [Full Text] [Related]

  • 14. Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
    Plissonneau M, Pansieri J, Heinrich-Balard L, Morfin JF, Stransky-Heilkron N, Rivory P, Mowat P, Dumoulin M, Cohen R, Allémann É, Tόth É, Saraiva MJ, Louis C, Tillement O, Forge V, Lux F, Marquette C.
    J Nanobiotechnology; 2016 Jul 25; 14(1):60. PubMed ID: 27455834
    [Abstract] [Full Text] [Related]

  • 15. Differential modification of Cys10 alters transthyretin's effect on beta-amyloid aggregation and toxicity.
    Liu L, Hou J, Du J, Chumanov RS, Xu Q, Ge Y, Johnson JA, Murphy RM.
    Protein Eng Des Sel; 2009 Aug 25; 22(8):479-88. PubMed ID: 19549717
    [Abstract] [Full Text] [Related]

  • 16. Transthyretin Inhibits Primary and Secondary Nucleations of Amyloid-β Peptide Aggregation and Reduces the Toxicity of Its Oligomers.
    Ghadami SA, Chia S, Ruggeri FS, Meisl G, Bemporad F, Habchi J, Cascella R, Dobson CM, Vendruscolo M, Knowles TPJ, Chiti F.
    Biomacromolecules; 2020 Mar 09; 21(3):1112-1125. PubMed ID: 32011129
    [Abstract] [Full Text] [Related]

  • 17. Copper mediated amyloid-β binding to Transthyretin.
    Ciccone L, Fruchart-Gaillard C, Mourier G, Savko M, Nencetti S, Orlandini E, Servent D, Stura EA, Shepard W.
    Sci Rep; 2018 Sep 13; 8(1):13744. PubMed ID: 30213975
    [Abstract] [Full Text] [Related]

  • 18. Cooperative stabilization of transthyretin by clusterin and diflunisal.
    Greene MJ, Klimtchuk ES, Seldin DC, Berk JL, Connors LH.
    Biochemistry; 2015 Jan 20; 54(2):268-78. PubMed ID: 25478940
    [Abstract] [Full Text] [Related]

  • 19. Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants.
    Quintas A, Vaz DC, Cardoso I, Saraiva MJ, Brito RM.
    J Biol Chem; 2001 Jul 20; 276(29):27207-13. PubMed ID: 11306576
    [Abstract] [Full Text] [Related]

  • 20. Uncovering the Mechanism of Aggregation of Human Transthyretin.
    Saelices L, Johnson LM, Liang WY, Sawaya MR, Cascio D, Ruchala P, Whitelegge J, Jiang L, Riek R, Eisenberg DS.
    J Biol Chem; 2015 Nov 27; 290(48):28932-43. PubMed ID: 26459562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.